Primary |
Product Used For Unknown Indication |
68.7% |
Drug Use For Unknown Indication |
7.1% |
Back Pain |
5.0% |
Intentional Drug Misuse |
4.2% |
Completed Suicide |
4.0% |
Pain |
3.3% |
Intentional Overdose |
2.1% |
Drug Abuse |
1.6% |
Depression |
0.7% |
Cancer Pain |
0.5% |
Abdominal Pain |
0.4% |
Breakthrough Pain |
0.4% |
Arthralgia |
0.3% |
Musculoskeletal Chest Pain |
0.3% |
Complex Regional Pain Syndrome |
0.2% |
Fibromyalgia |
0.2% |
Headache |
0.2% |
Intervertebral Disc Degeneration |
0.2% |
Investigation |
0.2% |
Muscle Relaxant Therapy |
0.2% |
|
Drug Abuse |
71.8% |
Substance Abuse |
5.3% |
Death |
4.5% |
Completed Suicide |
3.3% |
Toxicity To Various Agents |
2.1% |
Overdose |
1.8% |
Vomiting |
1.4% |
Somnolence |
1.3% |
Unresponsive To Stimuli |
1.3% |
Respiratory Depression |
1.0% |
Suicide Attempt |
1.0% |
Intentional Drug Misuse |
0.8% |
Accidental Death |
0.6% |
Drug Abuser |
0.6% |
Headache |
0.6% |
Multiple Drug Overdose |
0.6% |
Weight Decreased |
0.6% |
Drug Withdrawal Syndrome |
0.5% |
Pneumonia Aspiration |
0.5% |
Pulmonary Oedema |
0.5% |
|
Secondary |
Drug Use For Unknown Indication |
40.3% |
Back Pain |
21.7% |
Pain |
7.1% |
Multiple Myeloma |
4.7% |
Depression |
3.6% |
Hypertension |
3.4% |
Product Used For Unknown Indication |
3.4% |
Prophylaxis |
3.4% |
Breakthrough Pain |
2.1% |
Ill-defined Disorder |
1.3% |
Insomnia |
1.3% |
Analgesia |
1.1% |
Cancer Pain |
1.0% |
Neuralgia |
1.0% |
Arthropathy |
0.8% |
Drug Abuse |
0.8% |
Migraine |
0.8% |
Sleep Disorder |
0.8% |
Toxicity To Various Agents |
0.8% |
Back Injury |
0.6% |
|
Tooth Loss |
13.0% |
Vomiting |
11.7% |
Respiratory Depression |
9.1% |
Somnolence |
6.5% |
Syncope |
6.5% |
Drug Toxicity |
5.2% |
Multiple Drug Overdose |
5.2% |
Toxicity To Various Agents |
5.2% |
Unresponsive To Stimuli |
5.2% |
Pyelonephritis Chronic |
3.9% |
Self-medication |
3.9% |
Suicide Attempt |
3.9% |
Death |
2.6% |
Dyspnoea |
2.6% |
Face Oedema |
2.6% |
Intentional Overdose |
2.6% |
Malaise |
2.6% |
Pain |
2.6% |
Pneumonia Aspiration |
2.6% |
Pulmonary Oedema |
2.6% |
|
Concomitant |
Product Used For Unknown Indication |
19.0% |
Pain |
17.8% |
Drug Use For Unknown Indication |
12.1% |
Prophylaxis |
9.1% |
Multiple Sclerosis |
4.5% |
Back Pain |
3.9% |
Depression |
3.7% |
Hiv Infection |
3.0% |
Insomnia |
3.0% |
Hepatic Neoplasm Malignant |
2.9% |
Hypertension |
2.9% |
Rheumatoid Arthritis |
2.9% |
Castleman's Disease |
2.7% |
Cancer Pain |
2.6% |
Multiple Myeloma |
2.2% |
Constipation |
1.7% |
Asthma |
1.6% |
Anxiety |
1.5% |
Nausea |
1.4% |
Prophylaxis Of Nausea And Vomiting |
1.4% |
|
Tumour Lysis Syndrome |
19.3% |
Vomiting |
8.9% |
Pneumonia |
6.9% |
Weight Increased |
6.9% |
White Blood Cell Count Decreased |
6.9% |
Nausea |
5.0% |
Urinary Tract Infection |
4.5% |
Weight Decreased |
4.5% |
Pyrexia |
4.0% |
Upper Respiratory Tract Infection |
4.0% |
Headache |
3.5% |
Coronary Artery Disease |
3.0% |
Death |
3.0% |
Drug Prescribing Error |
3.0% |
Dry Skin |
3.0% |
Rash |
3.0% |
Thrombosis |
3.0% |
Withdrawal Syndrome |
3.0% |
Pain |
2.5% |
Pain In Extremity |
2.5% |
|
Interacting |
Drug Use For Unknown Indication |
80.0% |
Back Pain |
10.0% |
Pain |
10.0% |
|
|